作者: Michael D Holzman , Edward F Mitchel , Wayne A Ray , Walter E Smalley
DOI: 10.1016/S1072-7515(00)00746-8
关键词: Medical prescription 、 Surgery 、 Health care 、 Cohort 、 Disease 、 Medicine 、 Internal medicine 、 Esophageal disease 、 Medicaid 、 Reflux 、 GERD
摘要: Abstract Background: Gastroesophageal reflux disease (GERD) is a common disorder that may be effectively managed medically or surgically. Direct evaluations of medical resource use are needed to better understand the relative costs these alternatives. This study compared care for group patients receiving surgical treatment GERD with comparable management. Study Design: We conducted retrospective matched cohort Tennessee Medicaid (TennCare) undergoing in 1996 and who received therapy during same period. Administrative TennCare data provided computerized records could used identify measure healthcare use. There were 7,502 people met all conditions inclusion study, including at least two encounters diagnosis GERD. One hundred thirty-five underwent fundoplication constituted surgically treated cohort. The 250 persons selected randomly from remaining nonsurgical by age, gender, race, organization, acid suppression drug baseline year. principal outcome interest was total resources, prescription medication. Results: cohorts did not differ significantly demographic characteristics pharmaceuticals. During year prescribed 302 (95% CI: 270–334) days 292 267–317) treatment. Surgically more GERD-related outpatient resources (physician visits diagnostic testing) year, particularly 3 months before operation, when they had mean than four encounter-days. In followup pharmaceuticals decreased markedly These an average 123 94–153) therapy, which only 36% (339 [95% 308–370]). More 29% no drugs 6% group. number inpatient procedure 3.2 2.7–3.6), range 0 13 days. differences between groups other Conclusions: Our results show 1-year period followup, severe gastroesophageal led 64% postsurgical reduction medication use, increase services.